Cantila, Felecidad L.
HRN: 25-78-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
09/13/2024
09/19/2024
IVTT
500 Mg
OD
Complicated Urinary Tract Infection
Waiting Final Action
Indication: EmpiricCulture-directed Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes